Allergan Announces Stock Buyback Program

  • Allergan announced a stock buyback program of $2 billion, a week after disappointing news for drug in its pipeline
  • This buyback follows the completion of a separate buyback program of $15 billion
  • Also announced was the retirement of Allergan’s CFO, Tessa Hilado